Ga naar deals
TMT

Total Specific Solutions B.V. has acquired Forsikringens Datacenter A/S from a group of insurance companies

The shareholders of Forsikringens Datacenter A/S (FDC), Gjensidige, Bupa Global and Sygeforsikringen "danmark", have sold the company to Total Specific Solutions (TSS). Financial details have not been disclosed.

TSS is a leading provider of IT business solutions. It consists of independent business units that deliver solutions and services to their specific markets. With decades of experience, TSS is active in the health, public, retail, financial and legal service areas as well as in the audit and real estate industries. TSS is part of Constellation Software Inc. (CSI), listed on the Canadian Stock Exchange. With this acquisition, TSS enters the Danish software market and strengthens its foothold in the finance vertical.

FDC is one of Scandinavia’s largest suppliers of IT solutions for the insurance and pension industry. FDC has a broad reach and a large customer base totaling more than seven million policies in Denmark, Norway and Sweden, with tailored and specific software solutions. The firm was founded over 50 years ago through the collaboration of several insurance companies and has a profound knowledge of the insurance industry and software market.

This successful transaction originated from the combined expertise from Oaklins’ Danish and Dutch TMT sector teams. Oaklins' team in Denmark advised TSS in connection with the acquisition of FDC. Oaklins' team in the Netherlands has a long-standing relationship with TSS and introduced the Danish team, who executed the transaction. This deal is another example of the seamless cross-border cooperation within Oaklins, demonstrating the organization’s added value through its global execution capabilities, industry expertise and contacts.

“Oaklins has in-depth industry expertise in software and IT, and they really understand the industry's opportunities. FDC is a true vertical market software company and fits in well with the TSS group. As part of TSS, FDC will benefit from our know-how, financial strength and operational experience to ensure renewed focus and growth.”

Ramon Zanders

General Manager, Total Specific Solutions B.V.

Neem contact op met het dealteam

Daniel Sand

Partner
Kopenhagen, Denemarken
Oaklins Beierholm

Frederik van der Schoot

Managing Partner
Amsterdam, Nederland
Oaklins Netherlands

Mads Thomsen

Partner
Kopenhagen, Denemarken
Oaklins Beierholm

Gerelateerde deals

Niscon Inc. has been acquired by SGPS ShowRig
TMT

Niscon Inc. has been acquired by SGPS ShowRig

Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.

Lees verder
Fairfest Media has acquired WTE Miami
Zakelijke Dienstverlening | TMT

Fairfest Media has acquired WTE Miami

Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.

Lees verder
Banook, backed by Motion Equity, has acquired Fluidda
Gezondheidszorg | TMT

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.

Lees verder